GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Home injections for myasthenia gravis: a game changer for patient independence?
Disease control CompletedThis study looked at whether 62 people with generalized myasthenia gravis could learn to give themselves the drug rozanolixizumab at home using a syringe driver or manual push. After training, most participants successfully self-administered the correct dose at the right site. Th…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 26, 2026 07:46 UTC
-
New injection shows promise for managing rare muscle disease over time
Disease control CompletedThis study tested the long-term safety of a drug called efgartigimod, given as a shot under the skin, in 184 adults with generalized myasthenia gravis (a condition that causes muscle weakness). Participants received repeated treatment cycles as needed. The main goal was to check …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 07:45 UTC
-
Easier injections for muscle weakness: new device tested
Disease control CompletedThis study looked at whether people with generalized myasthenia gravis (a condition causing muscle weakness) can safely and effectively give themselves the drug zilucoplan using a new auto-injector device. Thirty-one adults who were already taking zilucoplan participated. The mai…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New dosing strategy aims to keep muscle weakness in check
Disease control CompletedThis study looked at two ways of giving the drug efgartigimod to people with generalized myasthenia gravis, a condition that causes muscle weakness. One group received the drug on a continuous schedule, while the other received it in cycles. The goal was to see which approach bet…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New drug shows promise for muscle weakness disease
Disease control CompletedThis study tested a drug called rozanolixizumab in 200 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants received either the drug or a placebo to see if it improved daily activities like talking, swallowing, and breathing. The goal was t…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New shot option for rare Muscle-Weakening disease shows promise
Disease control CompletedThis study looked at 26 adults with generalized myasthenia gravis, a condition that causes muscle weakness. They switched from an IV medicine to a daily shot called zilucoplan. The main goal was to see if the switch was safe and well-tolerated. Results help offer a more convenien…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 22, 2026 14:03 UTC